Glycomet Gp 1 Tablet

• Glycomet-GP 1 Tablet is used in the treatment of type 2 diabetes

• Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of GP Hypoglycemia (low blood glucose level) Headache Nausea Dizziness Weakness

If you experience any persistent or severe side effects, consult your doctor immediately.

• Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. GP 1 Tablet is to be taken with food.

• How GP Tablet works GP 1 Tablet is an antidiabetic medication. It works by increasing the amount of insulin released by the pancreas in order to lower blood glucose.

• 
  Alcohol:

  It is unsafe to consume alcohol with GP 1 Tablet.

• 
  Driving:

  Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

• 
  Kidney:

  GP 1 Tablet should be used with caution in patients with kidney disease. Dose adjustment of GP 1 Tablet may be needed. Please consult your doctor. Use of GP 1 Tablet is not recommended in patients with severe kidney disease. These patients can experience very low blood sugar levels which may become normal after a long time.

• 
  Liver:

  GP 1 Tablet should be used with caution in patients with liver disease. Dose adjustment of GP 1 Tablet may be needed. Please consult your doctor. However, the use of GP 1 Tablet is not recommended in patients with severe liver disease. These patients can experience very low blood sugar levels which may become normal after a long time.

• 
  Pregnancy:

  GP 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

• 
  Breastfeeding:

  GP 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with GP 1 Tablet